Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
20012.5k citationsCraig L. Bennett, Fred Ramsdell et al.Nature Geneticsprofile →
An essential role for Scurfin in CD4+CD25+ T regulatory cells
20032.3k citationsRoli Khattri, Tom Cox et al.Nature Immunologyprofile →
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
20012.0k citationsMary E. Brunkow, Eric W. Jeffery et al.Nature Geneticsprofile →
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy
20011.4k citationsFred Ramsdell, Mark W. Appleby et al.Nature Geneticsprofile →
Fas ligand mediates activation-induced cell death in human T lymphocytes.
1995812 citationsMark R. Alderson, Teresa W. Tough et al.The Journal of Experimental Medicineprofile →
Fas and FasL in the homeostatic regulation of immune responses
1995496 citationsDavid H. Lynch, Fred Ramsdell et al.profile →
Fas transduces activation signals in normal human T lymphocytes.
1993460 citationsMark R. Alderson, Teresa W. Tough et al.The Journal of Experimental Medicineprofile →
The activation antigen CD69
1994439 citationsSteven F. Ziegler, Fred Ramsdell et al.Stem Cellsprofile →
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation
2001434 citationsEric W. Jeffery, Fred Ramsdell et al.profile →
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
2006370 citationsHolm H. Uhlig, Janine L. Coombes et al.The Journal of Immunologyprofile →
Clonal Deletion Versus Clonal Anergy: The Role of the Thymus in Inducing Self Tolerance
1990293 citationsFred Ramsdell, B. J. Fowlkesprofile →
A Nondeletional Mechanism of Thymic Self Tolerance
1989281 citationsFred Ramsdell, B. J. Fowlkes et al.profile →
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
1994252 citationsFred Ramsdell, Elizabeth Baker et al.profile →
Opportunities for Treg cell therapy for the treatment of human disease
202370 citationsJeffrey A. Bluestone, Brent S. McKenzie et al.Frontiers in Immunologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Fred Ramsdell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Ramsdell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Ramsdell more than expected).
This network shows the impact of papers produced by Fred Ramsdell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Ramsdell. The network helps show where Fred Ramsdell may publish in the future.
Co-authorship network of co-authors of Fred Ramsdell
This figure shows the co-authorship network connecting the top 25 collaborators of Fred Ramsdell.
A scholar is included among the top collaborators of Fred Ramsdell based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Fred Ramsdell. Fred Ramsdell is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Bluestone, Jeffrey A., Brent S. McKenzie, Joshua Beilke, & Fred Ramsdell. (2023). Opportunities for Treg cell therapy for the treatment of human disease. Frontiers in Immunology. 14. 1166135–1166135.70 indexed citations breakdown →
2.
Ramsdell, Fred & Steven F. Ziegler. (2014). FOXP3 and scurfy: how it all began. Nature reviews. Immunology. 14(5). 343–349.164 indexed citations
Uhlig, Holm H., Janine L. Coombes, Christian Mottet, et al.. (2006). Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis. The Journal of Immunology. 177(9). 5852–5860.370 indexed citations breakdown →
Khattri, Roli, et al.. (2003). An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunology. 4(4). 337–342.2310 indexed citations breakdown →
Brunkow, Mary E., Eric W. Jeffery, Kathryn A. Hjerrild, et al.. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics. 27(1). 68–73.1960 indexed citations breakdown →
11.
Bennett, Craig L., Fred Ramsdell, Mary E. Brunkow, et al.. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics. 27(1). 20–21.2547 indexed citations breakdown →
12.
Appleby, Mark W., et al.. (1999). Cellular and molecular characterization of the scurfy mouse mutant.. PubMed. 162(5). 2546–54.158 indexed citations
13.
Alderson, Mark R., Teresa W. Tough, Terri Davis‐Smith, et al.. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes.. The Journal of Experimental Medicine. 181(1). 71–77.812 indexed citations breakdown →
Ziegler, Steven F., Fred Ramsdell, & Mark R. Alderson. (1994). The activation antigen CD69. Stem Cells. 12(5). 456–465.439 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.